Rajani Kanteti
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Tannin, Tannase and Anticancer Activities, Liver physiology and pathology, Cancer Genomics and Diagnostics, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma(2017)297 cited
- → The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma(2009)264 cited
- → Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer(2009)183 cited
- → Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment(2016)182 cited
- → Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation(2001)153 cited
- → FAK and paxillin, two potential targets in pancreatic cancer(2016)126 cited
- → Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion(2008)119 cited
- → EphA2 Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation(2010)115 cited
- → PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription(2009)108 cited
- → RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma(2011)103 cited